ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,365Medicare Part D Prescriptions Filled, Including Refills

Rank: 59 out of 6969

$1.09M Total Retail Price of All Prescriptions

Rank: 120 out of 6969

607 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 607 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

32% of this provider’s 607 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 19,005 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 1,588 1,411 1 4
HYDROCODONE-ACETAMINOPHEN 805 435 S3 2 3
LISINOPRIL-HYDROCHLOROTHIAZIDE 676 523 3 28
METFORMIN HCL 669 604 4 7
LISINOPRIL 647 547 5 2
METOPROLOL SUCCINATE 583 553 6 22
TAMSULOSIN HCL 527 502 7 23
CRESTOR 524 494 8 39
GLIMEPIRIDE 516 479 9 44
ZOLPIDEM TARTRATE 511 435 10 16
PRAVASTATIN SODIUM 508 455 11 19
OMEPRAZOLE 506 429 12 6
ATORVASTATIN CALCIUM 502 464 13 11
SIMVASTATIN 500 431 14 1
GABAPENTIN 383 306 15 17
METOPROLOL TARTRATE 373 328 16 13
IBUPROFEN 357 250 17 29
DIOVAN HCT 356 356 18 57
FUROSEMIDE 349 302 19 10
LOSARTAN-HYDROCHLOROTHIAZIDE 313 310 20 53
AMLODIPINE BESYLATE-BENAZEPRIL 303 301 21 91
MELOXICAM 295 267 22 36
LEVOTHYROXINE SODIUM 291 215 23 5
CARVEDILOL 282 261 24 25
BACLOFEN 258 204 25 86
ATENOLOL 252 204 26 9
BENAZEPRIL HCL 240 227 27 18
TRAMADOL HCL 229 195 28 27
HYDROCHLOROTHIAZIDE 224 191 29 8
CLONIDINE HCL 223 200 30 59
AVODART 183 183 31 108
BENICAR HCT 178 178 32 176
ACETAMINOPHEN-CODEINE 178 158 S3 32 73
PROAIR HFA 177 129 34 33
FLUOXETINE HCL 172 119 35 43
ALENDRONATE SODIUM 166 148 36 14
MECLIZINE HCL 162 151 37 100
JANUVIA 154 153 38 41
DIGOXIN 150 137 39 71
ADVAIR DISKUS 148 121 40 45
WARFARIN SODIUM 142 126 41 20
ATELVIA 138 137 42 111
DIOVAN 137 127 43 26
EXELON 127 121 44 157
POTASSIUM CHLORIDE 120 106 45 30
NAMENDA 119 106 46 51
ACTOS 115 98 47 61
LIPITOR 113 104 48 89
NEXIUM 109 76 49 52
CLOPIDOGREL 109 91 49 48
VESICARE 106 104 51 163
FLUTICASONE PROPIONATE 105 83 52 24
TRIAMCINOLONE ACETONIDE 102 89 53 55
PANTOPRAZOLE SODIUM 102 86 53 31
FAMOTIDINE 94 55 55 37
CELEBREX 94 94 55 67
ENALAPRIL MALEATE 91 90 57 56
ALLOPURINOL 88 71 58 35
LOVASTATIN 83 69 59 15
RANITIDINE HCL 82 60 60 46
PLAVIX 82 80 60 68
CARISOPRODOL 81 0 R 62 69
LOSARTAN POTASSIUM 78 72 63 12
PIOGLITAZONE HCL 78 70 R 63 174
NITROSTAT 77 73 65 210
BYSTOLIC 77 77 65 155
DOXAZOSIN MESYLATE 77 54 65 74
DONEPEZIL HCL 71 58 68 32
HYDRALAZINE HCL 69 61 69 106
PROPRANOLOL HCL 67 65 70 153
PAROXETINE HCL 65 37 71 65
CYMBALTA 65 50 71 72
SPIRONOLACTONE 64 49 73 102
VENTOLIN HFA 62 49 74 125
OLANZAPINE 61 59 75 139
ISOSORBIDE MONONITRATE ER 59 58 76 81
CITALOPRAM HBR 59 42 76 34
ONGLYZA 57 56 78 164
KLOR-CON 8 55 45 79 104
ZETIA 55 54 79 98
SERTRALINE HCL 55 26 79 38
ENABLEX 55 41 79 299
RISPERIDONE 54 28 83 88
DICLOFENAC SODIUM 53 50 84 78
PATADAY 53 52 84 213
FINASTERIDE 52 52 86 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 20, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.